1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Modeling Parkinson's disease and treatment complications in rodents : Potentials and pitfalls of the current options
- 2015
- Gene expression analyses identify narp contribution in the development of L-DOPA-induced dyskinesia
- 2014
- Striatal adaptations in experimental parkinsonism and L-DOPA-induced dyskinesia
- Emerging pharmacotherapies for Parkinson's Disease: Experimental studies in the rat
- Mitogen- and stress-activated protein kinase 1 is required for specific signaling responses in dopamine-denervated mouse striatum, but is not necessary for l-DOPA-induced dyskinesia
-
Chapter 22 - Rodent Models of Treatment-Related Complications in Parkinson Disease
Francardo, Veronica LU ; Iderberg, Hanna LU ; Lindgren, Hanna LU and Cenci Nilsson, Angela LU
(2014)
p.373-386
Mark
- 2010
-
Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease
Kobylecki, Christopher ; Cenci Nilsson, Angela LU
; Crossman, Alan R.
and Ravenscroft, Paula
(2010)
In Journal of Neurochemistry
114(2).
p.499-511
Mark
-
Neural grafting in Parkinson's disease: unraveling the mechanisms underlying graft-induced dyskinesia
Lane, Emma L. ; Björklund, Anders LU
; Dunnett, Stephen B.
and Winkler, Christian
(2010)
In Progress in Brain Research
184.
p.295-309
Mark
- 2009
- L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice
- 2007
-
Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
Mela, Flora ; Marti, Matteo ; Dekundy, Andrzej ; Danysz, Wojciech ; Morari, Michele and Cenci Nilsson, Angela LU
(2007)
In Journal of Neurochemistry
101(2).
p.483-497
Mark